Annual Non Current Assets
$22.73 M
+$1.72 M+8.18%
31 December 2023
Summary:
Keros Therapeutics annual long term assets is currently $22.73 million, with the most recent change of +$1.72 million (+8.18%) on 31 December 2023. During the last 3 years, it has risen by +$21.02 million (+1223.94%). KROS annual non current assets is now at all-time high.KROS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$27.23 M
+$4.92 M+22.04%
30 September 2024
Summary:
Keros Therapeutics quarterly long term assets is currently $27.23 million, with the most recent change of +$4.92 million (+22.04%) on 30 September 2024. Over the past year, it has increased by +$5.41 million (+24.82%). KROS quarterly non current assets is now at all-time high.KROS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.2% | +24.8% |
| 3 y3 years | +1223.9% | +600.2% |
| 5 y5 years | +1108.5% | - |
KROS Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1223.9% | at high | +614.4% |
| 5 y | 5 years | at high | +1223.9% | at high | +1485.6% |
| alltime | all time | at high | +1223.9% | at high | +1485.6% |
Keros Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.23 M(+22.0%) |
| June 2024 | - | $22.31 M(-1.7%) |
| Mar 2024 | - | $22.69 M(-0.2%) |
| Dec 2023 | $347.29 M(+21.5%) | $22.73 M(+4.2%) |
| Sept 2023 | - | $21.81 M(-0.8%) |
| June 2023 | - | $22.00 M(-1.0%) |
| Mar 2023 | - | $22.21 M(+5.7%) |
| Dec 2022 | $285.77 M | $21.01 M(+214.8%) |
| Sept 2022 | - | $6.67 M(+55.1%) |
| June 2022 | - | $4.30 M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.92 M(+2.9%) |
| Dec 2021 | $251.44 M(-6.1%) | $3.81 M(-2.0%) |
| Sept 2021 | - | $3.89 M(+90.2%) |
| June 2021 | - | $2.04 M(+16.9%) |
| Mar 2021 | - | $1.75 M(+1.8%) |
| Dec 2020 | $267.73 M(+2899.1%) | $1.72 M(-6.2%) |
| Sept 2020 | - | $1.83 M(-4.7%) |
| June 2020 | - | $1.92 M(-6.4%) |
| Mar 2020 | - | $2.05 M(+1.2%) |
| Dec 2019 | $8.93 M(-65.0%) | $2.03 M |
| Dec 2018 | $25.53 M | - |
FAQ
- What is Keros Therapeutics annual long term assets?
- What is the all time high annual non current assets for Keros Therapeutics?
- What is Keros Therapeutics annual non current assets year-on-year change?
- What is Keros Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Keros Therapeutics?
- What is Keros Therapeutics quarterly non current assets year-on-year change?
What is Keros Therapeutics annual long term assets?
The current annual non current assets of KROS is $22.73 M
What is the all time high annual non current assets for Keros Therapeutics?
Keros Therapeutics all-time high annual long term assets is $22.73 M
What is Keros Therapeutics annual non current assets year-on-year change?
Over the past year, KROS annual long term assets has changed by +$1.72 M (+8.18%)
What is Keros Therapeutics quarterly long term assets?
The current quarterly non current assets of KROS is $27.23 M
What is the all time high quarterly non current assets for Keros Therapeutics?
Keros Therapeutics all-time high quarterly long term assets is $27.23 M
What is Keros Therapeutics quarterly non current assets year-on-year change?
Over the past year, KROS quarterly long term assets has changed by +$5.41 M (+24.82%)